Steroid receptor coactivators 1, 2, and 3: Critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy
- 1 June 2011
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 348 (2), 430-439
- https://doi.org/10.1016/j.mce.2011.04.021
Abstract
No abstract availableKeywords
This publication has 126 references indexed in Scilit:
- Steroid Receptor Coactivator (SRC) Family: Masters of Systems BiologyJournal of Biological Chemistry, 2010
- Identification of novel ER-α target genes in breast cancer cells: Gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17β-estradiol and tamoxifenMolecular and Cellular Endocrinology, 2010
- Melanoma Antigen Gene Protein-A11 (MAGE-11) F-box Links the Androgen Receptor NH2-terminal Transactivation Domain to p160 CoactivatorsPublished by Elsevier BV ,2009
- Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) familyNature Reviews Cancer, 2009
- Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formationProceedings of the National Academy of Sciences, 2009
- Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNANature, 2008
- PKA-induced resistance to tamoxifen is associated with an altered orientation of ERα towards co-activator SRC-1The EMBO Journal, 2007
- Hypoxia-induced and stress-specific changes in chromatin structure and functionMutation Research, 2007
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003